n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Astrocytoma, Grade IV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adenis, A; Chollet, P; Cure, H; Fargeot, P; Fumoleau, P; Hanausk, A; Lentz, MA; Madelmont, JC; Roche, H; Terret, C | 1 |
1 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Astrocytoma, Grade IV
Article | Year |
---|---|
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Female; Glioblastoma; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Nitrosourea Compounds; Thrombocytopenia; Tomography, X-Ray Computed | 2000 |